A SURVEY OF THE TREATMENT OF 200 CASES OF BASAL CELL CARCINOMA (1959-1966 INCLUSIVE) = UNE REVUE DU TRAITEMENT DE 200 CAS D'EPITHELIOMAS BASO-CELLULAIRE (1959-1966 INCLUS)NEVRKLA E; NEWTON KA.1974; BRIT. J. DERMATOL.; G.B.; DA. 1974; VOL. 91; NO 4; PP. 429-433; BIBL. 16 REF.Article

PROPHYLACTIC LUNG IRRADIATION IN THE TREATMENT OF OSTEOGENIC SARCOMANEWTON KA; BARRETT A.1978; CLIN. RADIOL.; GBR; DA. 1978; VOL. 29; NO 5; PP. 493-496; BIBL. 18 REF.Article

SYMPTON RELIEF WITH LEVAMISOLE IN STAGE IV HODGKIN'S DISEASE.PHILLIPS RH; RETSAS S; NEWTON KA et al.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 5074; PP. 1447-1448; BIBL. 5 REF.Article

EVALUATION OF HUMAN LYMPHOBLASTOID INTERFERON IN ADVANCED MALIGNANT MELANOMA = ETUDE DE L'INTERFERON LYMPHOBLASTOIDE HUMAIN DANS LES MELANOMES AVANCESRETSAS S; PRIESTMAN TJ; NEWTON KA et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 2; PP. 273-276; ABS. ENG; BIBL. 6 REF.; GRAPHArticle

EFFECT OF SPLENIC IRRADIATION ON CIRCULATING COLONY-FORMING CELLS IN CHRONIC GRANULOCYTIC LEUKAEMIA.BARRETT AJ; LONGHURST P; HUMBLE JG et al.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6071; PP. 1259; BIBL. 5 REF.Article

SPLIT COURSE RADIATION IN INOPERABLE CARCINOMA OF THE BRONCHUSMADDEN FJF; ENGLISH JSC; MOORE AK et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 9; PP. 1175-1177; BIBL. 6 REF.Article

COMBINATION OF RADIOTHERAPY AND RAZOXANE (ICRF 159) FOR CHONDROSARCOMARYALL RDH; BATES T; NEWTON KA et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 3; PP. 891-895; BIBL. 14 REF.Article

HODGKIN'S DISEASE. A CLINICO-PATHOLOGICAL STUDY OF 250 CASES WITH A 5-YEAR FOLLOW-UP = MALADIE DE HODGKIN. ETUDE ANATOMO-CLINIQUE DE 250CAS AVEC UNE SURVEILLANCE DE 5ANSNEWTON KA; MACKENZIE DH; SPITTLE MF et al.1972; BRIT. J. CANCER; G.B.; DA. 1972; VOL. 27; NO 1; PP. 80-91; BIBL. 20REF.Serial Issue

COMBINED TREATMENT OF SOFT TISSUE AND OSTEOSARCOMAS BY RADIATION AND ICRF 159RYALL RDH; HANHAM IWF; NEWTON KA et al.1974; CANCER; U.S.A.; DA. 1974; VOL. 34; NO 4; PP. 1040-1045; BIBL. 16REF.Article

COMPARISON OF RADIOTHERAPY WITH AND WITHOUT RAZOXANE (ICRF 159) IN THE TREATMENT OF SOFT TISSUE SARCOMAS.HELLMANN K; RYALL RDH; MACDONALD E et al.1978; CANCER; U.S.A.; DA. 1978; VOL. 41; NO 1; PP. 100-107; BIBL. 24 REF.Article

DOUBLE BLIND CONTROLLED CLINICAL TRIAL OF RADIATION PLUS RAZOXANE (ICRF 159) VERSUS RADIATION PLUS PLACEBO IN THE TREATMENT OF HEAD AND NECK CANCER.BAKOWSKI MT; MACDONALD E; MOULD RF et al.1978; INTERACTION J. RAD. ONCOL. BIOL. PHYS.; U.S.A.; DA. 1978; VOL. 4; NO 1-2; PP. 115-119; BIBL. 7 REF.; (INTERACTION RADIAT. ANTITUMOR DRUGS. STANFORD CADEMEM. SYMP.; LONDON; 1976)Conference Paper

CLINICAL TRIAL OF COMBINATION CHEMOTHERAPY AND SPECIFIC ACTIVE IMMUNOTHERAPY IN DISSEMINATED MELANOMA.NEWLANDS ES; OON CJ; ROBERTS JT et al.1976; BRIT. J. CANCER; G.B.; DA. 1976; VOL. 34; NO 2; PP. 174-179; BIBL. 16 REF.Article